Because Asian patients , when compared with non-Asian patients , are believed to be more susceptible to bleeding , we evaluated the effects of ticagrelor compared with clopidogrel in Asian ( n = 1,106 ) and non-Asian ( n = 17,515 ) patients with acute coronary syndrome enrolled in the PLATO study .